Boehringer Ingelheim UK & Ireland is pleased to announce the appointment of Vani Manja as its new Country Managing Director and Head of Human Pharma. Vani has been with Boehringer Ingelheim for over 11 years, in successful leadership roles in Germany, the United States and most recently as General Manager, India .
Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Pvt Ltd to co-market Cospiaq®, Cospiaq Met™ and Xilingio® in India.
The recent four injunctions restrain domestic drugmakers from infringing the Patent of Linagliptin marketed under the trade name, ‘Trajenta’, in the country
Finance Minister Nirmala Sitharaman while presenting the Union Budget 2022 in the Parliament on Tuesday, identified pharmaceuticals and genomics as sunrise opportunities.